![William Earnest Pullman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
William Earnest Pullman
Director/Board Member at
USL Pharma International UK Ltd.
Profile
William Earnest Pullman is currently a Director at Proximagen Group Plc and a Director at USL Pharma International UK Ltd. He previously worked as the Chief Medical Officer & Senior Vice President at Cubist Pharmaceuticals LLC, the Chief Development Officer & Executive VP at Dyax Corp., and the Senior Vice President-Exploratory Development at TransForm Pharmaceuticals, Inc. Pullman holds a doctorate degree from both the Australian National University and The University of Western Australia.
William Earnest Pullman active positions
| Companies | Position | Start |
|---|---|---|
USL Pharma International UK Ltd.
 USL Pharma International UK Ltd. Pharmaceuticals: MajorHealth Technology Operates as holding company whose subsidiaries develops drugs for the treatment of neurological and inflammatory disorders | Director/Board Member | 2013-12-17 |
Proximagen Group Ltd.
 Proximagen Group Ltd. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics designed for the treatment of central nervous system diseases | Director/Board Member | 2013-12-17 |
Former positions of William Earnest Pullman
| Companies | Position | End |
|---|---|---|
| DYAX CORP. | Chief Tech/Sci/R&D Officer | - |
TransForm Pharmaceuticals, Inc.
 TransForm Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs | Corporate Officer/Principal | - |
| CUBIST PHARMACEUTICALS INC | Chief Tech/Sci/R&D Officer | - |
Training of William Earnest Pullman
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
2
1st degree connections
7
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Cubist Pharmaceuticals LLC
 Cubist Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Engages in research, development and commercialization of pharmaceutical products | Health Technology |
Dyax Corp.
 Dyax Corp. BiotechnologyHealth Technology Operates as a biopharmaceutical company that engages in development and commercialization of novel biotherapeutics | Health Technology |
Proximagen Group Ltd.
Proximagen Group Ltd. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics designed for the treatment of central nervous system diseases | Health Technology |
Australian National University
 Australian National University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
TransForm Pharmaceuticals, Inc.
TransForm Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs | Health Technology |
The University of Western Australia
 The University of Western Australia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
USL Pharma International UK Ltd.
USL Pharma International UK Ltd. Pharmaceuticals: MajorHealth Technology Operates as holding company whose subsidiaries develops drugs for the treatment of neurological and inflammatory disorders | Health Technology |
- Stock Market
- Insiders
- William Earnest Pullman
